CIAM
XGN icon

Caitong International Asset Management’s Exagen XGN Stock Holding History

Caitong International Asset Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6 Buy
+2
New +$8 ﹤0.01% 2252

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Caitong International Asset Management's XGN Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Exagen (XGN) in Q1 2026: 2 shares worth $6. The stake represents ﹤0.01% of the portfolio and ranks #2252 among its holdings.

61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Caitong International Asset Management held 2 shares of Exagen worth $6 as of Q1 2026.
  • Exagen was a new Caitong International Asset Management position in Q1 2026.
  • Exagen made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2252 holding.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.